Please enable JavaScript to continue using this application.

Compare $GANX vs $GRML | Chartloom

Compare

$GANX vs $GRML

Gain Therapeutics Inc · Greenland Mines Ltd

GANX

Gain Therapeutics Inc

GRML

Greenland Mines Ltd

Compare $GANX vs $GRML

Comparing Gain Therapeutics Inc and Greenland Mines Ltd

GANXGain Therapeutics Inc

GRMLGreenland Mines Ltd

GANXGain Therapeutics Inc

Market cap

$70M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-48.4%

52W performance

-20.8%

FCF yield

-27.1%

GRMLGreenland Mines Ltd

Market cap

$778M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-77.9%

52W performance

-77.9%

FCF yield

-1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GANX

GRML

Detailed metrics comparison

GANX

Gain Therapeutics Inc

GRML

Greenland Mines Ltd

Market Cap

GANX$70M

GRML$778M

Enterprise Value

GANX$57M

GRML$769M

Price

GANX$1.64

GRML$5.17

P/E Ratio

GANXN/A

GRMLN/A

P/S Ratio

GANX466.44x

GRML0.00x

EV/Sales

GANX386.81x

GRML0.00x

EV/EBITDA

GANX0.00x

GRML0.00x

P/B Ratio

GANX6.61x

GRML1.20x

P/FCF Ratio

GANXN/A

GRMLN/A

EV/FCF

GANX-3.02x

GRML-54.20x

PEG Ratio

GANXN/A

GRMLN/A

Forward P/E (NTM)

GANXN/A

GRMLN/A

Forward P/S (NTM)

GANXN/A

GRMLN/A

Revenue (TTM)

GANX$0

GRML$0

Revenue Growth (YoY)

GANXN/A

GRMLN/A

Forward Rev Growth

GANX180.0%

GRML0.0%

Gross Margin (TTM)

GANX0.0%

GRML0.0%

Operating Margin (TTM)

GANX0.0%

GRML0.0%

EBITDA Margin (TTM)

GANX0.0%

GRML0.0%

Net Margin (TTM)

GANX0.0%

GRML0.0%

FCF Margin (TTM)

GANXN/A

GRMLN/A

Net Income (TTM)

GANX$-20M

GRML$-22M

FCF (TTM)

GANX$-19M

GRML$-14M

EPS (TTM)

GANX-$0.47

GRML-$8.60

ROE (TTM)

GANX-16158.0%

GRML-6762.0%

ROA (TTM)

GANX-11836.0%

GRML-6029.0%

ROIC (TTM)

GANX-15673.0%

GRML-6731.0%

Cash

GANX$13M

GRML$9M

Debt

GANX$344K

GRML$298K

Net Cash/Debt

GANX$13M

GRML$9M

Current Ratio (TTM)

GANX4.36x

GRML10.09x

Quick Ratio (TTM)

GANX4.11x

GRML7.78x

Debt/Equity (TTM)

GANX0.03x

GRML0.01x

Debt/Assets (TTM)

GANX0.0%

GRML0.0%

Interest Coverage (TTM)

GANXN/A

GRMLN/A

Net Debt/EBITDA (TTM)

GANX0.00x

GRML0.00x

Beta

GANX0.21

GRML4.66

52W Performance

GANX-20.8%

GRML-77.9%

YTD Performance

GANX-48.4%

GRML-77.9%

% from 52W High

GANX-62.2%

GRML-81.2%

% from 52W Low

GANX7.2%

GRML83.3%

Asset Turnover (TTM)

GANX0.01x

GRML0.00x

FCF Yield (TTM)

GANX-27.1%

GRML-1.8%

Earnings Yield (TTM)

GANX-28.7%

GRML-2.8%

Dividend Yield (TTM)

GANXN/A

GRMLN/A

Rule of 40

GANX0.0

GRML0.0

EV/GP/RG

GANXN/A

GRMLN/A

Ticker research

View GANX research View GRML research

Metric	GANX Gain Therapeutics Inc	GRML Greenland Mines Ltd
Market & Valuation
Market Cap	$70M	$778M
Enterprise Value	$57M	$769M
Price	$1.64	$5.17
P/E Ratio	N/A	N/A
P/S Ratio	466.44x	0.00x
EV/Sales	386.81x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.61x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	-54.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	180.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-22M
FCF (TTM)	$-19M	$-14M
EPS (TTM)	-$0.47	-$8.60
ROE (TTM)	-16158.0%	-6762.0%
ROA (TTM)	-11836.0%	-6029.0%
ROIC (TTM)	-15673.0%	-6731.0%
Financial Health
Cash	$13M	$9M
Debt	$344K	$298K
Net Cash/Debt	$13M	$9M
Current Ratio (TTM)	4.36x	10.09x
Quick Ratio (TTM)	4.11x	7.78x
Debt/Equity (TTM)	0.03x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.21	4.66
52W Performance	-20.8%	-77.9%
YTD Performance	-48.4%	-77.9%
% from 52W High	-62.2%	-81.2%
% from 52W Low	7.2%	83.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-27.1%	-1.8%
Earnings Yield (TTM)	-28.7%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GANX research	View GRML research

Valuation

P/S Ratio

GRML

0.00x

GANX

466.44x

EV/FCF

GRML

-54.20x

GANX

-3.02x

Growth & revenue

Forward Revenue Growth

GANX

180.0%

GRML

0.0%

Profitability & performance

Gross Margin

GANX

0.0%

GRML

0.0%

ROE

GRML

-6762.0%

GANX

-16158.0%

FCF Yield %

GRML

-1.8%

GANX

-27.1%

52-Week Performance

GANX

-20.8%

GRML

-77.9%

Detailed metrics comparison

GANX

Gain Therapeutics Inc

GRML

Greenland Mines Ltd

Market Cap

GANX$70M

GRML$778M

Enterprise Value

GANX$57M

GRML$769M

Price

GANX$1.64

GRML$5.17

P/E Ratio

GANXN/A

GRMLN/A

P/S Ratio

GANX466.44x

GRML0.00x

EV/Sales

GANX386.81x

GRML0.00x

EV/EBITDA

GANX0.00x

GRML0.00x

P/B Ratio

GANX6.61x

GRML1.20x

P/FCF Ratio

GANXN/A

GRMLN/A

EV/FCF

GANX-3.02x

GRML-54.20x

PEG Ratio

GANXN/A

GRMLN/A

Forward P/E (NTM)

GANXN/A

GRMLN/A

Forward P/S (NTM)

GANXN/A

GRMLN/A

Revenue (TTM)

GANX$0

GRML$0

Revenue Growth (YoY)

GANXN/A

GRMLN/A

Forward Rev Growth

GANX180.0%

GRML0.0%

Gross Margin (TTM)

GANX0.0%

GRML0.0%

Operating Margin (TTM)

GANX0.0%

GRML0.0%

EBITDA Margin (TTM)

GANX0.0%

GRML0.0%

Net Margin (TTM)

GANX0.0%

GRML0.0%

FCF Margin (TTM)

GANXN/A

GRMLN/A

Net Income (TTM)

GANX$-20M

GRML$-22M

FCF (TTM)

GANX$-19M

GRML$-14M

EPS (TTM)

GANX-$0.47

GRML-$8.60

ROE (TTM)

GANX-16158.0%

GRML-6762.0%

ROA (TTM)

GANX-11836.0%

GRML-6029.0%

ROIC (TTM)

GANX-15673.0%

GRML-6731.0%

Cash

GANX$13M

GRML$9M

Debt

GANX$344K

GRML$298K

Net Cash/Debt

GANX$13M

GRML$9M

Current Ratio (TTM)

GANX4.36x

GRML10.09x

Quick Ratio (TTM)

GANX4.11x

GRML7.78x

Debt/Equity (TTM)

GANX0.03x

GRML0.01x

Debt/Assets (TTM)

GANX0.0%

GRML0.0%

Interest Coverage (TTM)

GANXN/A

GRMLN/A

Net Debt/EBITDA (TTM)

GANX0.00x

GRML0.00x

Beta

GANX0.21

GRML4.66

52W Performance

GANX-20.8%

GRML-77.9%

YTD Performance

GANX-48.4%

GRML-77.9%

% from 52W High

GANX-62.2%

GRML-81.2%

% from 52W Low

GANX7.2%

GRML83.3%

Asset Turnover (TTM)

GANX0.01x

GRML0.00x

FCF Yield (TTM)

GANX-27.1%

GRML-1.8%

Earnings Yield (TTM)

GANX-28.7%

GRML-2.8%

Dividend Yield (TTM)

GANXN/A

GRMLN/A

Rule of 40

GANX0.0

GRML0.0

EV/GP/RG

GANXN/A

GRMLN/A

Ticker research

View GANX research View GRML research

Metric	GANX Gain Therapeutics Inc	GRML Greenland Mines Ltd
Market & Valuation
Market Cap	$70M	$778M
Enterprise Value	$57M	$769M
Price	$1.64	$5.17
P/E Ratio	N/A	N/A
P/S Ratio	466.44x	0.00x
EV/Sales	386.81x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.61x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	-54.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	180.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-22M
FCF (TTM)	$-19M	$-14M
EPS (TTM)	-$0.47	-$8.60
ROE (TTM)	-16158.0%	-6762.0%
ROA (TTM)	-11836.0%	-6029.0%
ROIC (TTM)	-15673.0%	-6731.0%
Financial Health
Cash	$13M	$9M
Debt	$344K	$298K
Net Cash/Debt	$13M	$9M
Current Ratio (TTM)	4.36x	10.09x
Quick Ratio (TTM)	4.11x	7.78x
Debt/Equity (TTM)	0.03x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.21	4.66
52W Performance	-20.8%	-77.9%
YTD Performance	-48.4%	-77.9%
% from 52W High	-62.2%	-81.2%
% from 52W Low	7.2%	83.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-27.1%	-1.8%
Earnings Yield (TTM)	-28.7%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GANX research	View GRML research